Latest news

AstraZeneca and RQ Biotech enter into licensing agreement to develop antibodies against COVID-19

UK-based startup and British-Swedish pharma giant AstraZeneca have signed a licensing agreement amounting to over $150 million....

Kelun sells cancer drug development rights to Merck in a deal worth $1.4 billion

United States-based Merck & Co has made an addition to its cancer-fighting drugs after entering into a...

German Pharmaceutical and Medical Cannabis Products Distributor to be acquired by Franchise Global Health

The projected outcome of this acquisition is a boost in operations and the initiation of collaborations in...

Avillion and AstraZeneca combination medicine presents positive results for people living with asthma 

The New England Journal of Medicine has published the results of Avillion and AstraZeneca’s PT027 after participation...

Orion signs $16 million deal with Jemincare for development of novel non-opioid pain treatment

The deal involves a $16 million payment from Orion to Jemincare with milestones as well as royalty...

Several drug recalls hit the US market, including Pfizer’s Accupril

Leading pharmaceutical companies have been hit by...

Why Focus on Treating Diseases Instead of Curing Them?

It’s a tragic irony: So much money...

Janssen reports positive topline results for Tremfya in Crohn’s at week 48

The IL-23 Pathway and Its Pivotal Role in Inflammatory Bowel Disease Research The incidence...

Oral medication for Covid, Paxlovid boosted in Britain, courtesy of the national trial

Pfizer's COVID-19 immunization and antiviral give little indication of dialing back in the pandemic's third year. The...

The European Commission allows Beovu to be used in the Treatment of DME

Following success in Phase III RCT KESTREL and KITE, Novartis’ Beovu will be used for diabetic macular...

Novartis to combine its pharma and oncology operations to save $1 Billion

Novartis has opted for a corporate restructure of operations to aid in cash-saving. This involves the combining...

Bayer to Spend $2.2 Billion in the Expansion of Manufacturing Abilities with Cell and Gene Therapies

German pharmaceutical company Bayer is looking to invest over $2 billion to enhance its production and supply...

Surprising Things Your Walk Can Say About You

If you tend to veer to the left while walking, could be you’re anxious. And if you...

Popular

Most popular life news you must read today

NRx Pharma’s ZYESAMI™ approved for emergency use Covid critical care in Georgia

As of July 27, a global biopharmaceutical company, NRx Pharmaceuticals, has announced that the Prime Minister of the Nation of Georgia

Eton Pharma gets FDA nod on Rezipres® for treatment of hypotension in anesthesia settings

Rezipres, an ephedrine HCL (hydrochloride) injectable manufactured by Eton Pharmaceuticals, has been approved by FDA to treat

Infrastructure bill, drug price controls and the impact on the pharma industry

Should the infrastructure bill be enacted, with "Aspects of H.R. 3" that include measures which peg U.S. prices of a number of prescription

Commercial

German Pharmaceutical and Medical Cannabis Products Distributor to be acquired by Franchise Global Health

The projected outcome of this acquisition is a boost in operations and the initiation of collaborations in...

Orion signs $16 million deal with Jemincare for development of novel non-opioid pain treatment

The deal involves a $16 million payment from Orion to Jemincare with milestones as well as royalty...

Oral medication for Covid, Paxlovid boosted in Britain, courtesy of the national trial

Pfizer's COVID-19 immunization and antiviral give little indication of dialing back in the pandemic's third year. The...

Novartis to combine its pharma and oncology operations to save $1 Billion

Novartis has opted for a corporate restructure of operations to aid in cash-saving. This involves the combining...

Insud Pharma and Fresenius Kabi join efforts to grow mAbxience

German Fresenius Kabi to acquire Insud Pharmaceutical’s biotech company mAbxience in a new deal. As per the...

Sinopharm and TSB’s Covid-19 antibody treatment is set to hit the Chinese market

The two partners will proceed with distribution of Brii Bio/TSB Therapeutics’ monoclonal antibody (mAb) treatment in China,...

Information Technology

Kelun sells cancer drug development rights to Merck in a deal worth $1.4 billion

United States-based Merck & Co has made an addition to its cancer-fighting...

Halozyme Therapeutics receives $25 million from Chugai Pharmaceuticals for the use of subcutaneous delivery technology

An agreement has been reached between Halozyme Therapeutics and Chugai Pharmaceutical where...

Triastek and Siemens form a partnership to drive digital transformation in the pharmaceutical sector

Chinese pharmaceutical companies Triastek and Siemens have signed a deal to become...

$30 million strategic agreement reached between Sanofi and DarioHealth

France- based Sanofi and DarioHealth have signed a five-year deal amounting to...

Regulatory

Several drug recalls hit the US market, including Pfizer’s Accupril

Leading pharmaceutical companies have been hit by...
- Advertisement -

Research & Development

Turn Biotechnologies to move onto the next stage of cell rejuvenation program with the help of pharma organizations.

Turn Biotechnologies has been able to successfully secure fundraising from global pharmaceutical...

Covid-19 Oral Treatment to be developed jointly by Sen-Jam Pharmaceuticals and KVK Tech

According to the partnership, KVK Tech will formulate the oral COVID medication...

Access to Lumykras increased in the U.K through collaboration between Amgen and NHS

The NHS has reached a landmark agreement with Amgen Pharmaceuticals to expand...

Santhera advances gene therapy for LAMA2 MD through deal with Seal Therapeutics

Santhera Pharmaceuticals and Seal Therapeutics' partnership aims to develop gene therapy for...

Market Access

Spikevax COVID-19 Vaccine recalled by Moderna and Rovi

Moderna and Rovi pharmaceuticals have issued a recall of more than 750,000...

Bayer to Spend $2.2 Billion in the Expansion of Manufacturing Abilities with Cell and Gene Therapies

German pharmaceutical company Bayer is looking to invest over $2 billion to...

Cannabinoid drugs plant in the UK worth $100 million started by Jazz Pharmaceuticals

Construction begins in the United Kingdom of a manufacturing plant for the...

Pfizer’s COVID-19 pill to be manufactured by generic pharmaceutical companies

Over 90 low and middle-income countries will be able to gain access...

Centrient Pharmaceuticals doubles its statin production capacity with a new manufacturing facility

Centrient Pharmaceuticals, a worldwide leader in antifungal agents, sustainable antibiotics, and statins, has announced that the manufacturing

Novartis subsidiary Sandoz increasing its antibiotics manufacturing capacity in Europe with $183m investment

Sandoz, a Novartis company , is planning to invest $183 million (€150 million) in Kundl, Spain, Austria, and Palafolls to expand its antibiotic production network in Europe.

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

AstraZeneca and RQ Biotech enter into licensing agreement to develop antibodies against COVID-19

UK-based startup and British-Swedish pharma giant AstraZeneca...